An ordinary New Mexico investment-adviser representative files Form U4 through CRD/IARD and pays $50 initially and at annual renewal. The ordinary qualification route is Series 65 or Series 7 plus Series 66, subject to the rule’s bounded recent-registration and listed current-designation alternatives. Registration renews through CRD/IARD by December 31 and termination uses Form U5.

Prelicensing education

Education requirement explanation
Qualification and any accepted alternative or waiver must match the current state rule; examination passage alone is not registration.

Background

Fingerprint / background instructions
Form U4 disclosures and regulator follow-up apply; no separate fingerprint requirement is inferred unless expressly documented.

Application

Application fee
The current official regulator page and statutory packet support $50 initial and $50 renewal fees; any dual agent/IAR exception is conditional.
Application channel / system
The firm files Form U4 through CRD/IARD and Form U5 on termination; filing and qualification do not create registration.
Official application reference
https://www.rld.nm.gov/securities-division/firms-industry-professionals/investment-advisers/

Renewal & maintenance

CE hours
No general New Mexico state IAR CE or EVEP mandate is asserted from the reviewed current page and packet.

Portability

Portability / mobility notes
Registration is firm-, function-, and jurisdiction-specific; examination validity and approval are separate.

Military / veteran / spouse

Military experience / education credit
No broad military credit is asserted unless expressly documented.

Source governance

Primary authoritative source
https://www.rld.nm.gov/wp-content/uploads/2026/03/NM-Investment-Adviser-Registration-Packet.pdf
Last verified date
2026-08-31
Verification status
Verified
Review / recheck date
2026-09-30

Compare education providers

Alphabetical options; compensation never determines eligibility or placement. Confirm the exact course and jurisdiction before enrolling. This directory is not exhaustive.

No currently verified published offerings match. Check official provider and regulator resources; additional options may exist.